A big thank you to all our sponsors, exhibitors and attendees. Cantech 2019 was a great success!
Mr. Janzen has been involved in the Life Sciences industry for over 20 years. He currently is the Chairman and CEO of Aequus Pharmaceuticals and the Founder and Managing Director of NorthView Ventures, a private equity entity which invests in and provides strategic advisory services to a number of Life Sciences companies. Prior to that, he was President and CEO of Cardiome Pharma, a NASDAQ listed drug development company that raised over $300M from investors and completed over $1Billion in licensing deals during his tenure. In 2010 Cardiome’s lead product Brinavess was approved and launched in Europe by Merck. Prior to that, Mr. Janzen was an investment banker with Cormark Securities, acting as Managing Director of Life Sciences. Mr. Janzen is a past winner of Vancouver’s Top 40 under 40 award, is the past Chairman of Life Sciences British Columbia, has served as a Director of Biotech Canada and sits as a Director on a number of public and private boards.Read less
See Doug Janzen at the Cantech Investment Conference.